The 44th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 47th Survey in 2021)

This survey was performed in order to investigate the incidence of adverse reactions to radiopharmaceuticals in FY2021 in Japan. It was based on responses to questionnaires sent to nuclear medicine institutions. Replies were obtained from 970 institutions out of 1,194 to which the questionnaire had...

Full description

Saved in:
Bibliographic Details
Published inKaku igaku. The Japanese journal of nuclear medicine Vol. 60; no. 1; p. 1
Main Authors Okazawa, Hidehiko, Uehara, Tomoya, Kuji, Ichiei, Higashi, Tatsuya, Yoshimura, Mana
Format Journal Article
LanguageJapanese
Published Japan 2023
Subjects
Incidence
Japan - epidemiology
Nuclear Medicine
Radiopharmaceuticals - adverse effects
Surveys and Questionnaires
Japan
radiopharmaceuticals
adverse reactions
defective products
Online AccessGet more information

Cover

More Information
Summary:This survey was performed in order to investigate the incidence of adverse reactions to radiopharmaceuticals in FY2021 in Japan. It was based on responses to questionnaires sent to nuclear medicine institutions. Replies were obtained from 970 institutions out of 1,194 to which the questionnaire had been sent. A total of 928,921 radiopharmaceutical administrations were reported. Twelve cases of adverse reactions were reported. The incidence of adverse reactions per 100,000 cases was 1.3. Three cases of defective products were reported. The incidence of defective products per 100,000 cases was 0.3.
ISSN:2189-9932
DOI:10.18893/kakuigaku.rp.2331